BELLUS Health Inc. (TSE:BLU – Get Free Report)’s share price was down 0.1% on Monday . The stock traded as low as C$19.24 and last traded at C$19.48. Approximately 28,666 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 59,471 shares. The stock had previously closed at C$19.50. […]
BELLUS Health (TSE:BLU) Share Price Crosses Below 50 Day Moving Average of $19.53 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
(Alliance News) - GSK PLC on Wednesday said it completed its acquisition of Quebec-based late-stage biopharmaceutical firm Bellus Health Inc for a total equity value of USD2.0 billion.
GSK, the Brentford, London-based pharmaceutical company, back in Apr.